drugset / Trial / NCT00095290

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

NCT00095290

Phase 4 Completed 400 enrolled Bristol-Myers Squibb Sanofi · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Albumin in the urine is usually a signal that you might be at risk of cardiovascular complications. The purpose of this study is to determine if the albumin in your urine can be decreased by the treatment regimen that consists of irbesartan taken at the same time with ramipril.

Timeline

Start
2004-09
Primary completion
2005-11
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Irbesartan Small molecule 300 mg Oral
Comparator Ramipril Small molecule 10 mg Oral

Indications